TSE:4412 stock news
This page provides real-time market news, earnings updates, and company announcements related to Science Arts, Inc. (TSE:4412).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-20 10:23 JST
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Finviz2026-02-18 13:06:40
Aether Holdings Issues Year-End Letter to Shareholders
Finviz2026-02-18 13:33:35
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
Finviz2026-02-18 13:33:35
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
Finviz2026-02-18 14:30:10
On February 18, Palantir rose over 4%! Mizuho Securities upgraded its rating to Outperform with a target price of $195.
老虎证券2026-02-18 15:18:08
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-18 21:09:41
Herbalife (NYSE:HLF) Beats Q4 CY2025 Sales Expectations, Stock Jumps 11.7%
Finviz2026-02-18 21:45:39
Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)'s Science-Driven Psilocybin Therapies as Key Growth Drivers
Finviz2026-02-19 02:30:37
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:03:41
Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting
Finviz2026-02-19 12:03:41
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
Finviz2026-02-19 12:03:42
BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.
Finviz2026-02-19 12:33:04
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist and Eversense 365
Finviz2026-02-19 13:03:14
Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors
Finviz2026-02-19 13:06:40
Where Food Comes From, Inc. Expands Premium Protein Portfolio with Whole Foods Market Adoption of RaiseWell Certified for Beef
Finviz2026-02-19 13:33:12
Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026
Finviz2026-02-19 13:33:14
SAIC Launches Alliance to Accelerate State-Led Execution of $50 Billion Rural Healthcare Transformation Program
Finviz2026-02-19 13:33:12
ASP Isotopes Announces Establishment of Quantum Leap Energy Strategic Advisory Board, Bolstering its Plans for the Nuclear Fuel Sector
Finviz2026-02-19 13:48:08
What Does the Street Have to Say About Bristol-Myers Squibb Company (BMY)?
Finviz2026-02-19 14:57:45
REITs Set for a 2026 Rebound? 7 Top Picks as Rate Cuts Approach
Finviz2026-02-19 18:21:08
Bio-Rad Laboratories, Inc. (BIO) Achieves Modest Revenue Growth and Robust Free Cash Flow Growth
Finviz2026-02-19 19:45:38
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
Finviz2026-02-19 21:04:00
NN, Inc. to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, March 5, 2026
Finviz2026-02-19 21:09:43
Prospective Validation Study in JAAD Demonstrates Castle Biosciences' AdvanceAD-Tx Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
Finviz2026-02-19 22:51:34
On February 18, Palantir rose over 4%! Mizuho Securities upgraded its rating to Outperform with a target price of $195.
老虎证券2026-02-18 15:18:08
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-18 21:09:41
Herbalife (NYSE:HLF) Beats Q4 CY2025 Sales Expectations, Stock Jumps 11.7%
Finviz2026-02-18 21:45:39
Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)'s Science-Driven Psilocybin Therapies as Key Growth Drivers
Finviz2026-02-19 02:30:37
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:03:41
Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting
Finviz2026-02-19 12:03:41
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
Finviz2026-02-19 12:03:42
BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.
Finviz2026-02-19 12:33:04
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist and Eversense 365
Finviz2026-02-19 13:03:14
Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors
Finviz2026-02-19 13:06:40
Where Food Comes From, Inc. Expands Premium Protein Portfolio with Whole Foods Market Adoption of RaiseWell Certified for Beef
Finviz2026-02-19 13:33:12
Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026
Finviz2026-02-19 13:33:14
SAIC Launches Alliance to Accelerate State-Led Execution of $50 Billion Rural Healthcare Transformation Program
Finviz2026-02-19 13:33:12
ASP Isotopes Announces Establishment of Quantum Leap Energy Strategic Advisory Board, Bolstering its Plans for the Nuclear Fuel Sector
Finviz2026-02-19 13:48:08
What Does the Street Have to Say About Bristol-Myers Squibb Company (BMY)?
Finviz2026-02-19 14:57:45
REITs Set for a 2026 Rebound? 7 Top Picks as Rate Cuts Approach
Finviz2026-02-19 18:21:08
Bio-Rad Laboratories, Inc. (BIO) Achieves Modest Revenue Growth and Robust Free Cash Flow Growth
Finviz2026-02-19 19:45:38
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
Finviz2026-02-19 21:04:00
NN, Inc. to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, March 5, 2026
Finviz2026-02-19 21:09:43
Prospective Validation Study in JAAD Demonstrates Castle Biosciences' AdvanceAD-Tx Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
Finviz2026-02-19 22:51:34
TSE:4412 stock price change
On the last trading day, TSE:4412 stock closed at 2383.00 JPY, with a price change of -3.91% for the day.
Trade stock futuresTSE:4412 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more